Pango Therapeutics(PGTX)

Biotechnology company that has seen significant recent stock price appreciation.

1 Insight

Investment Insights

AI-generated insights about Pango Therapeutics from various financial sources

Thursday, September 11, 2025

Very Bearish

A 10% owner (Third Rock Ventures) with a very good track record of timing sales has made their largest individual sales ever after the stock ran up 250%, suggesting a notable bearish outlook.